Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: Results from a large population-based follow-up study

导出原文传递

翻译打印收藏纠错

作者： Ruiter,R. ^[1] ; Visser,L.E. ^[2] ; VnHerk-Sukel,M.P.P. ^[3] ; Coebergh,J.W.W. ^[4] ; Haak,H.R. ^[5] ; Geelhoed-Duijvestijn,P.H. ^[6] ; Straus,S.M.J.M. ^[7] ; Herings,R.M.C. ^[8] ; Stricker,B.H.Ch.

作者单位： PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands, Department of Health Policy and ^[1] Department of Epidemiology, Erasmus MC, P.O. Box 2040, 3000 CA, Rotterdam, Netherlands, Drug Safety ^[2] Dutch Medicines Evaluation Board, The Hague, Netherlands, Department of Medical Informatics ^[3] Department of Public Health, Erasmus MC, Rotterdam, Netherlands ^[4] Department of Internal Medicine, Maxima Medical Centre, Eindhoven, Netherlands ^[5] PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands ^[6] Department of Epidemiology, Erasmus MC, P.O. Box 2040, 3000 CA, Rotterdam, Netherlands, Department ^[7] Department of Internal Medicine, Medical Centre Haaglanden, The Hague, Netherlands ^[8]

关键词 Breast cancer Cancer Insulin Insulin analogues Insulin glargine

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交